GETINGE Price to Sales Ratio 2016-2024 | GNGBY
Historical PS ratio values for GETINGE (GNGBY) over the last 10 years. The current P/S ratio for GETINGE as of May 13, 2025 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| GETINGE P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 2025-05-09 | 19.02 | 1.61 | |
| 2024-09-30 | 21.09 | $11.78 | 1.79 |
| 2024-06-30 | 16.62 | $11.59 | 1.43 |
| 2024-03-31 | 19.30 | $11.16 | 1.73 |
| 2023-12-31 | 21.32 | $11.02 | 1.94 |
| 2023-09-30 | 16.99 | $10.55 | 1.61 |
| 2023-06-30 | 16.76 | $10.38 | 1.61 |
| 2023-03-31 | 22.97 | $10.37 | 2.22 |
| 2022-12-31 | 19.57 | $10.29 | 1.90 |
| 2022-09-30 | 16.28 | $10.66 | 1.53 |
| 2022-06-30 | 21.75 | $10.92 | 1.99 |
| 2022-03-31 | 37.59 | $11.31 | 3.32 |
| 2021-12-31 | 40.55 | $11.58 | 3.50 |
| 2021-09-30 | 37.15 | $11.94 | 3.11 |
| 2021-06-30 | 35.07 | $12.57 | 2.79 |
| 2021-03-31 | 25.56 | $12.34 | 2.07 |
| 2020-12-31 | 21.49 | $11.93 | 1.80 |
| 2020-09-30 | 20.07 | $11.51 | 1.74 |
| 2020-06-30 | 17.05 | $10.59 | 1.61 |
| 2020-03-31 | 17.38 | $10.39 | 1.67 |
| 2019-12-31 | 16.79 | $10.32 | 1.63 |
| 2019-09-30 | 12.65 | $10.30 | 1.23 |
| 2019-06-30 | 14.24 | $10.24 | 1.39 |
| 2019-03-31 | 10.46 | $10.23 | 1.02 |
| 2018-12-31 | 8.07 | $10.21 | 0.79 |
| 2018-09-30 | 10.31 | $7.95 | 1.30 |
| 2018-06-30 | 8.16 | $8.95 | 0.91 |
| 2018-03-31 | 9.97 | $10.63 | 0.94 |
| 2017-12-31 | 12.78 | $11.56 | 1.11 |
| 2017-09-30 | 13.14 | $15.05 | 0.87 |
| 2017-06-30 | 13.52 | $15.13 | 0.89 |
| 2017-03-31 | 12.17 | $14.56 | 0.84 |
| 2016-12-31 | 10.97 | $14.60 | 0.75 |
| 2016-09-30 | 13.25 | $14.77 | 0.90 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.000B | $3.288B |
| Getinge AB develops, manufactures and sells products and services for operating rooms, intensive-care units, hospital wards, sterilization departments, elderly care for life science companies and institutions. The company's operating segments consists of Medical Systems, Extended Care and Infection Control. It operates primarily in the United Kingdom, France, the United States and Australia. Getinge AB is headquartered in Gothenburg, Sweden. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $143.728B | 26.96 |
| Elevance Health (ELV) | United States | $94.145B | 12.15 |
| CVS Health (CVS) | United States | $81.986B | 10.19 |
| Cencora (COR) | United States | $53.983B | 18.77 |
| Natera (NTRA) | United States | $21.477B | 0.00 |
| DiDi Global (DIDIY) | China | $21.462B | 32.57 |
| BioMerieux (BMXMF) | France | $15.263B | 0.00 |
| Solventum (SOLV) | United States | $12.941B | 13.70 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.036B | 0.00 |
| Revvity (RVTY) | United States | $11.610B | 19.98 |
| Doximity (DOCS) | United States | $11.396B | 59.26 |
| ICON (ICLR) | Ireland | $11.324B | 10.53 |
| CochLear (CHEOY) | Australia | $11.195B | 0.00 |
| Viatris (VTRS) | United States | $10.516B | 3.61 |
| Medpace Holdings (MEDP) | United States | $9.017B | 23.95 |
| Avantor (AVTR) | United States | $8.859B | 12.87 |
| HealthEquity (HQY) | United States | $8.361B | 41.13 |
| Sonic Healthcare (SKHHY) | Australia | $8.215B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.027B | 13.77 |
| Amplifon S.p.A (AMFPF) | Italy | $4.966B | 26.21 |
| Bausch + Lomb (BLCO) | Canada | $4.202B | 24.77 |
| BrightSpring Health Services (BTSG) | United States | $3.894B | 36.05 |
| Sotera Health (SHC) | United States | $3.832B | 21.77 |
| Surgery Partners (SGRY) | United States | $2.982B | 38.77 |
| Alignment Healthcare (ALHC) | United States | $2.952B | 0.00 |
| Concentras Parent (CON) | United States | $2.771B | 16.01 |
| Organon (OGN) | United States | $2.264B | 2.41 |
| Ardent Health Partners (ARDT) | United States | $2.121B | 9.04 |
| Premier (PINC) | United States | $2.101B | 14.38 |
| Progyny (PGNY) | United States | $1.886B | 41.51 |
| PACS (PACS) | United States | $1.698B | 0.00 |
| GeneDx Holdings (WGS) | United States | $1.683B | 64.83 |
| GoodRx Holdings (GDRX) | United States | $1.669B | 31.07 |
| Teladoc Health (TDOC) | United States | $1.289B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.234B | 9.39 |
| Agilon Health (AGL) | United States | $1.229B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.000B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $0.998B | 0.00 |
| CareDx (CDNA) | United States | $0.911B | 14.23 |
| AMN Healthcare Services Inc (AMN) | United States | $0.866B | 8.11 |
| Embecta (EMBC) | United States | $0.725B | 4.89 |
| QDM (QDMI) | Hong Kong, SAR China | $0.690B | 0.00 |
| Nutex Health (NUTX) | United States | $0.689B | 13.50 |
| Enhabit (EHAB) | United States | $0.530B | 43.58 |
| InnovAge Holding (INNV) | United States | $0.513B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.513B | 13.59 |
| Sonida Senior Living (SNDA) | United States | $0.512B | 0.00 |
| LifeMD (LFMD) | United States | $0.389B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.363B | 0.00 |
| SBC Medicals (SBC) | United States | $0.359B | 0.00 |
| Beauty Health (SKIN) | United States | $0.220B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.202B | 0.00 |
| Oncology Institute (TOI) | United States | $0.193B | 0.00 |
| DocGo (DCGO) | United States | $0.147B | 24.08 |
| Sera Prognostics (SERA) | United States | $0.087B | 0.00 |
| So-Young (SY) | China | $0.087B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.087B | 0.00 |
| KindlyMD (KDLY) | United States | $0.082B | 0.00 |
| OncoCyte (OCX) | United States | $0.080B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.076B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.054B | 0.00 |
| Biodesix (BDSX) | United States | $0.053B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.031B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.030B | 0.00 |
| ModivCare (MODV) | United States | $0.018B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.012B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.011B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.006B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |